Clinical trial
A Randomized, Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Polidocanol Injectable Foam 0.5%, 1.0%, or 2.0% Compared to Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence
NCT01072877 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Polidocanol Injectable Foam 0.5%, 1.0%, or 2.0% Compared to Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- November 30, 2012
- Enrollment
- 279 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.